PRS24 COMPARISON OF TWO ECONOMIC MODELS IN THE EVALUATION OF THE COST-EFFECTIVENESS OF TRIPLE THERAPY TREATMENT FOR ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Matthew Taylor and Michelle Green provide a valuable insight into methods of vital cost-effectiveness analysis of combination inhalers for the management of chronic obstructive pulmonary disease.